Numerous authorities and institutions in Germany and the EU contribute to having veterinary medicinal products available for as many treatable diseases as possible.

The application form including required annexes as well as information on how to apply for the approval of clinical trials according to §10 of the Veterinary Medicinal Products Act (TAMG) can be found here.

Veterinary medicinal products that are intended to be placed on the market must go through a corresponding application procedure. Special regulations exist for homeopathic products and veterinary medicinal products for certain pet animals.

Active substances intended to be used for the treatment of food-producing animals are subject to strict legal regulations in the EU.

Veterinary medicinal products continue to be monitored and evaluated once they have been authorised. Even if therapy is performed with greatest care, the occurrence of adverse drug reactions cannot always be avoided.

The BVL fulfils various tasks to limit antibiotic resistance in the field of animal health under the umbrella of the German Antibiotic Resistance Strategy (DART 2020).

Since 28 January 2022 a new legislation with regard to veterinary medicinal products has been applied. Here you will find details of former legislation that was applied until 28 January 2022 as well as important transitional arrangements.

The crisis management for veterinary medicinal products acts as an interface between European partner authorities as well as national and international stakeholders.